<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://ltrc.sciwiki.in/index.php?action=history&amp;feed=atom&amp;title=AM-251_%28%E0%A6%93%E0%A6%B7%E0%A7%81%E0%A6%A7%29</id>
	<title>AM-251 (ওষুধ) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://ltrc.sciwiki.in/index.php?action=history&amp;feed=atom&amp;title=AM-251_%28%E0%A6%93%E0%A6%B7%E0%A7%81%E0%A6%A7%29"/>
	<link rel="alternate" type="text/html" href="https://ltrc.sciwiki.in/index.php?title=AM-251_(%E0%A6%93%E0%A6%B7%E0%A7%81%E0%A6%A7)&amp;action=history"/>
	<updated>2026-10-18T11:09:34Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://ltrc.sciwiki.in/index.php?title=AM-251_(%E0%A6%93%E0%A6%B7%E0%A7%81%E0%A6%A7)&amp;diff=6465&amp;oldid=prev</id>
		<title>Digantasen: ইংরেজি উইকিপিডিয়ার “AM-251 (drug)” নিবন্ধের বাংলা অনুবাদ</title>
		<link rel="alternate" type="text/html" href="https://ltrc.sciwiki.in/index.php?title=AM-251_(%E0%A6%93%E0%A6%B7%E0%A7%81%E0%A6%A7)&amp;diff=6465&amp;oldid=prev"/>
		<updated>2026-10-15T08:39:33Z</updated>

		<summary type="html">&lt;p&gt;ইংরেজি উইকিপিডিয়ার “AM-251 (drug)” নিবন্ধের বাংলা অনুবাদ&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:AM2512d.svg|thumb]]&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
! colspan=&amp;quot;2&amp;quot; | তথ্যছক&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;verifiedrevid&amp;#039;&amp;#039;&amp;#039; || 407629142&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;drug_name&amp;#039;&amp;#039;&amp;#039; || AM-251&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;iupac_name&amp;#039;&amp;#039;&amp;#039; || 1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-&amp;#039;&amp;#039;N&amp;#039;&amp;#039;-(1-piperidyl)pyrazole-3-carboxamide&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;width&amp;#039;&amp;#039;&amp;#039; || 160&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;routes_of_administration&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;excretion&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;cas_number_ref&amp;#039;&amp;#039;&amp;#039; || CAS&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;cas_number&amp;#039;&amp;#039;&amp;#039; || 183232-66-8&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;unii_ref&amp;#039;&amp;#039;&amp;#039; || FDA&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;unii&amp;#039;&amp;#039;&amp;#039; || 3I4FA44MAI&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;pubchem&amp;#039;&amp;#039;&amp;#039; || 2125&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;iuphar_ligand&amp;#039;&amp;#039;&amp;#039; || 3317&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chemspiderid_ref&amp;#039;&amp;#039;&amp;#039; || chemspider&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chemspiderid&amp;#039;&amp;#039;&amp;#039; || 2040&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chembl_ref&amp;#039;&amp;#039;&amp;#039; || EBI&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chembl&amp;#039;&amp;#039;&amp;#039; || 285932&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chebi_ref&amp;#039;&amp;#039;&amp;#039; || EBI&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chebi&amp;#039;&amp;#039;&amp;#039; || 90724&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;c&amp;#039;&amp;#039;&amp;#039; || 22&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;h&amp;#039;&amp;#039;&amp;#039; || 21&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;cl&amp;#039;&amp;#039;&amp;#039; || 2&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;i&amp;#039;&amp;#039;&amp;#039; || 1&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;n&amp;#039;&amp;#039;&amp;#039; || 4&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;o&amp;#039;&amp;#039;&amp;#039; || 1&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;smiles&amp;#039;&amp;#039;&amp;#039; || O=C(NN1CCCCC1)c4nn(c2ccc(Cl)cc2Cl)c(c3ccc(I)cc3)c4C&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchi_ref&amp;#039;&amp;#039;&amp;#039; || chemspider&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchi&amp;#039;&amp;#039;&amp;#039; || 1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchikey_ref&amp;#039;&amp;#039;&amp;#039; || chemspider&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchikey&amp;#039;&amp;#039;&amp;#039; || BUZAJRPLUGXRAB-UHFFFAOYSA-N&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;AM-251&amp;#039;&amp;#039;&amp;#039; হলো [[wikipedia:Cannabinoid receptor type 1|CB&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt;]] [[ক্যানাবিনয়েড|ক্যানাবিনয়েড]] রিসেপ্টরের একটি [[ইনভার্স অ্যাগোনিস্ট|inverse agonist]]। AM-251 গাঠনিকভাবে [[রিমোনাব্যান্ট|rimonabant]]-এর অত্যন্ত কাছাকাছি; উভয়ই হলো [[wikipedia:Biarylpyrazole|biarylpyrazole]] শ্রেণির [[ক্যানাবিনয়েড রিসেপ্টর অ্যান্টাগনিস্ট|cannabinoid receptor antagonist]]। AM-251-এ, [[পাইরাজোল|pyrazole]] বলয়ের C-5 অবস্থানে থাকা [[wikipedia:Phenyl|phenyl]] প্রতিস্থাপকের সাথে যুক্ত &amp;#039;&amp;#039;p&amp;#039;&amp;#039;-[[wikipedia:Chloro|chloro]] গ্রুপটিকে একটি &amp;#039;&amp;#039;p&amp;#039;&amp;#039;-[[wikipedia:Iodine|iodo]] গ্রুপ দ্বারা প্রতিস্থাপন করা হয়েছে। এর ফলে উৎপন্ন যৌগটি [[রিমোনাব্যান্ট|rimonabant]]-এর তুলনায় [[wikipedia:Cannabinoid receptor type 1|CB&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; রিসেপ্টর]]-এর প্রতি কিছুটা বেশি [[বিয়োজন ধ্রুবক#Protein-ligand binding|বাইন্ডিং অ্যাফিনিটি]] (K&amp;lt;sub&amp;gt;i&amp;lt;/sub&amp;gt; মান ৭.৫ nM) প্রদর্শন করে, যেখানে rimonabant-এর K&amp;lt;sub&amp;gt;i&amp;lt;/sub&amp;gt; মান ১১.৫ nM। তবে, rimonabant-এর তুলনায় AM-251, CB&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; রিসেপ্টরের ক্ষেত্রে প্রায় দ্বিগুণ বেশি সিলেক্টিভ বা নির্বাচনী।&amp;lt;ref&amp;gt;(February 1999). &amp;quot;Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists&amp;quot;. &amp;#039;&amp;#039;Journal of Medicinal Chemistry&amp;#039;&amp;#039;. 42 (4) 769–776. doi:[https://doi.org/10.1021/jm980363y 10.1021/jm980363y].&amp;lt;/ref&amp;gt; rimonabant-এর মতোই এটি একটি μ-opioid রিসেপ্টর অ্যান্টাগনিস্ট,&amp;lt;ref&amp;gt;(October 2012). &amp;quot;AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies&amp;quot;. &amp;#039;&amp;#039;Neuropharmacology&amp;#039;&amp;#039;. 63 (5) 905–915. doi:[https://doi.org/10.1016/j.neuropharm.2012.06.046 10.1016/j.neuropharm.2012.06.046].&amp;lt;/ref&amp;gt; যা ব্যথানাশক প্রভাবকে হ্রাস করে।&amp;lt;ref&amp;gt;(October 2012). &amp;quot;AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies&amp;quot;. &amp;#039;&amp;#039;Neuropharmacology&amp;#039;&amp;#039;. 63 (5) 905–915. doi:[https://doi.org/10.1016/j.neuropharm.2012.06.046 10.1016/j.neuropharm.2012.06.046].&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
AM251 অগ্ন্যাশয় ([[wikipedia:Pancreatic cancer|pancreatic cancer]]) এবং কোলন ক্যান্সারের ([[wikipedia:Colon cancer|colon cancer]]) কোষের বিরুদ্ধে &amp;#039;&amp;#039;[[wikipedia:In vitro|in vitro]]&amp;#039;&amp;#039; অ্যান্টিমেলানোমা কার্যকারিতা প্রদর্শন করেছে।&amp;lt;ref&amp;gt;(August 2015). [https://arpi.unipi.it/retrieve/handle/11568/750318/395886/Post-Print_2015_Carpi%20Nieri%20Anti-Cancer%20Drugs.pdf AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells]. &amp;#039;&amp;#039;Anti-Cancer Drugs&amp;#039;&amp;#039;. 26 (7) 754–762. doi:[https://doi.org/10.1097/CAD.0000000000000246 10.1097/CAD.0000000000000246].&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== আরও দেখুন ==&lt;br /&gt;
* [[wikipedia:Discovery and development of Cannabinoid Receptor 1 Antagonists|ক্যানাবিনয়েড রিসেপ্টর ১ অ্যান্টাগনিস্টের আবিষ্কার ও উন্নয়ন]]&lt;br /&gt;
&lt;br /&gt;
== তথ্যসূত্র ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&amp;#039;&amp;#039;উৎস:&amp;#039;&amp;#039; ইংরেজি উইকিপিডিয়ার “AM-251 (drug)” নিবন্ধের অনুবাদ।&lt;br /&gt;
&amp;#039;&amp;#039;মূল নিবন্ধ:&amp;#039;&amp;#039; https://en.wikipedia.org/wiki/AM-251_(drug)&lt;br /&gt;
&amp;#039;&amp;#039;এই অনুবাদটি স্বয়ংক্রিয়ভাবে প্রস্তুত করা হয়েছে।&amp;#039;&amp;#039;&lt;/div&gt;</summary>
		<author><name>Digantasen</name></author>
	</entry>
</feed>